{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:50:05Z","timestamp":1781067005191,"version":"3.54.1"},"reference-count":65,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal Community Psychology"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The purpose of this qualitative study is to assess facilitating factors and barriers for medications to treat opioid use disorder (MOUD) initiation among justice\u2010involved individuals in one rural Appalachian community, as well as how those factors may differ across the three types of Food and Drug Administration (FDA) approved medications. Qualitative interviews were conducted with rural justice\u2010involved individuals (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200910) with a history of opioid use in the target community. Overall, participants demonstrated knowledge of the different types of MOUD and their pharmacological properties, but limited overall health literacy around opioid use disorder and MOUD treatment. Treatment access was hampered by transportation, time burdens, and costs. Findings call for research into improving health literacy education, training, and resources to decrease stigma and increase access to MOUD, particularly in light of the ongoing opioid crisis. State policies also need to increase access to all FDA medications among justice\u2010involved individuals, as well as supporting a care continuum from facility entry, release, and community re\u2010entry.\n                  <\/jats:p>","DOI":"10.1002\/jcop.23029","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T12:59:21Z","timestamp":1679057961000},"page":"997-1014","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Facilitating factors and barriers for use of medications to treat opioid use disorder (MOUD) among justice\u2010involved individuals in rural Appalachia"],"prefix":"10.1002","volume":"52","author":[{"given":"Michele","family":"Staton","sequence":"first","affiliation":[{"name":"Department of Behavioral Science University of Kentucky College of Medicine Lexington Kentucky USA"},{"name":"Center on Drug and Alcohol Research, University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Pike","sequence":"additional","affiliation":[{"name":"Department of Behavioral Science University of Kentucky College of Medicine Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Tillson","sequence":"additional","affiliation":[{"name":"Center on Drug and Alcohol Research, University of Kentucky Lexington Kentucky USA"},{"name":"Department of Sociology University of Kentucky College of Arts and Sciences Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Lofwall","sequence":"additional","affiliation":[{"name":"Department of Behavioral Science University of Kentucky College of Medicine Lexington Kentucky USA"},{"name":"Center on Drug and Alcohol Research, University of Kentucky Lexington Kentucky USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"e_1_2_9_2_1","unstructured":"American Society of Addiction Medicine. (2015).The national practice guideline for the use of medications in the treatment of addiction involving opioid use.www.ASAM.org"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12503"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-7-3"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2018.02.024"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/nad.12044"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-018-0124-2"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0887403419838029"},{"key":"e_1_2_9_9_1","first-page":"2015","volume-title":"Informing Public Safety and Public Health Efforts to Address Kentucky's Drug Overdose Burden","author":"Bush A.","year":"2018"},{"key":"e_1_2_9_10_1","unstructured":"Centers for Disease Control and Prevention. (2018).2018 Annual Surveillance Report of Drug\u2010Related Risks and Outcomes\u2014United States. Surveillance Special Report. Centers for Disease Control and Prevention U.S. Department of Health and Human Services.https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-cdc-drug-surveillance-report.pdf"},{"key":"e_1_2_9_11_1","unstructured":"Centers for Disease Control and Prevention. (2022).U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 \u2013 But Are Still Up 15%.https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2022\/202205.htm"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108283"},{"key":"e_1_2_9_13_1","unstructured":"Commonwealth of Kentucky Department of Corrections. (2021).Addiction Services of Kentucky.https:\/\/corrections.ky.gov\/Divisions\/ask\/Pages\/default.aspx"},{"key":"e_1_2_9_14_1","volume-title":"Qualitative Inquiry and Research Design: Choosing Among Five Approaches","author":"Creswell J.","year":"2018"},{"key":"e_1_2_9_15_1","volume-title":"Practice guidelines for the administration of buprenorphine for treating opioid use disorder. HHS Notice, 86 Fed. Reg. 22439","author":"Department of Health and Human Services","year":"2021"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221103859"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.04.010"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.10.001"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.07.005"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2016.12.015"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102768"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108651"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000866"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2019.1706552"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2022.0019"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-019-0145-5"},{"key":"e_1_2_9_27_1","unstructured":"Kentucky Office of Drug Control Policy. (2022).2021 Overdose Fatality Report.https:\/\/odcp.ky.gov\/Pages\/Reports.aspx"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505409"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.12894"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.305728"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109100"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003002"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13779"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(69)90007-7"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1342662"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1129389"},{"key":"e_1_2_9_39_1","unstructured":"National Survey on Drug Use and Health. (2020).2019 NSDUH Detailed Tables.National Survey on Drug Use and Health."},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2015.01.004"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.08.002"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.07.004"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010862"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2014.891615"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000584"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102704"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1635555"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2021.1914109"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40352-021-00143-9"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S81602"},{"key":"e_1_2_9_51_1","unstructured":"Sinkman D. H. &Dorchak G.(2022).Using the Americans with Disabilities Act to Reduce Overdose Deaths 70(113)."},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1385631"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.13023\/jah.0301.02"},{"key":"e_1_2_9_54_1","unstructured":"Steel M. &Mirzaian M.(2021).Kentucky Resident Inpatient Hospitalizations for Nonfatal Drug Overdoses 2016\u20132020."},{"key":"e_1_2_9_55_1","unstructured":"Substance Abuse and Mental Health Services. (2018).Medicaid Coverage of Medication\u2010Assisted Treatment for Alcohol and Opioid Use Disorders and of Medication for the Reversal of Opioid Overdose.https:\/\/store.samhsa.gov\/product\/Medicaid-Coverage-of-Medication-Assisted-Treatment-for-Alcohol-and-Opioid-Use-Disorders-and-of-Medication-for-the-Reversal-of-Opioid-Overdose\/SMA18-5093"},{"key":"e_1_2_9_56_1","unstructured":"Substance Abuse and Mental Health Services & Administration. (2021).Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals Policymakers Patients and Families.https:\/\/store.samhsa.gov\/product\/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document\/PEP21-02-01-002"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-013-0110-x"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4098047"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01813-4"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.29158\/JAAPL.200127-20"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2019.09.001"},{"key":"e_1_2_9_62_1","volume-title":"National Snapshot: Access To Medications For Opioid Use Disorder In U.S. Jails And Prisons","author":"Weizman S.","year":"2021"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694597"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12527"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0558"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694599"}],"container-title":["Journal of Community Psychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcop.23029","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jcop.23029","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcop.23029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T09:47:59Z","timestamp":1729158479000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcop.23029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/jcop.23029"],"URL":"https:\/\/doi.org\/10.1002\/jcop.23029","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JCOP.23029\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JCOP.23029\/v1\/review1","asserted-by":"object"}]},"ISSN":["0090-4392","1520-6629"],"issn-type":[{"value":"0090-4392","type":"print"},{"value":"1520-6629","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"2022-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}